deferoxamine has been researched along with Osteomyelitis in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loesberg, AC | 1 |
| Martin, WB | 1 |
| McLean, TW | 1 |
| Kurth, S | 1 |
| Gee, B | 1 |
2 other studies available for deferoxamine and Osteomyelitis
| Article | Year |
|---|---|
Altered biodistribution of Ga-67 citrate in an iron-overloaded patient with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Blood Transfusion; Bone and Bones; Citrates; Citric Acid; Deferoxamine; | 1994 |
Pelvic osteomyelitis in a sickle-cell patient receiving deferoxamine.
Topics: Adolescent; Anemia, Sickle Cell; Chelation Therapy; Deferoxamine; Humans; Ilium; Injections, Subcuta | 1996 |